Daejeon, South Korea

MD Bioalpha Co., Ltd.


USPTO Granted Patents = 5

% Expired Patents = 80.0



Forward Citations = 10

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Myunggyu Park (3 out of 3 patents)

silverMedal Taehwan Kwak (3 out of 4 patents)

bronzeMedal In Geun Jo (2 out of 7 patents)

4.  Sang-Ku Yoo (2 out of 6 patents)

5.  Tae Hwan Kwak (1 out of 8 patents)

6.  Jong-Kook Park (1 out of 1 patent)

7.  Myung-Gyu Park (1 out of 1 patent)

8.  Mi Hee Choi (1 out of 1 patent)

9.  Myoung Sook Shin (1 out of 1 patent)

10.  Ji Yeon Kim (1 out of 2 patents)

11.  Tae-Hwan Kwak (1 patent)

12.  Sang-ku Yoo (0 patent)

13.  In Geum Jo (0 patent)

14.  Tae Hwan 103-503 Seogeunaemaeul Sk Apt Kwak (0 patent)

15.  Myoung Sook 611 Samjeongateutel Shin (0 patent)


5 patents:

Company Overview
Md Bioalpha Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative medical products. With a strong focus on quality and innovation, Md Bioalpha is dedicated to improving healthcare outcomes and enhancing the well-being of patients worldwide. The company's diverse portfolio includes pharmaceuticals, medical devices, and diagnostic tools, all designed to meet the evolving needs of the healthcare industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#105 in Daejeon

#1,879 in South Korea

Daejeon, KR
Daejeon, South Korea
Forward Citations = 10

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: MD Bioalpha Co., Ltd.. Retrieved from https://idiyas.com/company/md-bioalpha-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…